Comment on: Efficacy and Safety of Mycophenolate Mofetil versus Intravenous Pulse Cyclophosphamide as Induction Therapy in Proliferative Lupus Nephritis

被引：0
|
作者：
Ziaie, Shadi [1 ]
Moradi, Omid [2 ]
Saffaei, Ali [2 ]
机构：
[1] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Clin Pharm, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Clin Pharm, Student Res Comm, Tehran, Iran
来源：
IRANIAN JOURNAL OF KIDNEY DISEASES | 2019年 / 13卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：347 / 347
页数：1
相关论文
共 50 条
  • [31] Induction therapy for pediatric onset class IV lupus nephritis: Mycophenolate Mofetil versus Cyclophosphamide
    Marwa Chbihi
    Laurye-Anne Eveillard
    Quentin Riller
    Romain Brousse
    Romain Berthaud
    Pierre Quartier
    Rémi Salomon
    Marina Charbit
    Marina Avramescu
    Nathalie Biebuyck
    Laurène Dehoux
    Nicolas Garcelon
    Jean-Paul Duong-Van-Huyen
    Brigitte Bader-Meunier
    Olivia Boyer
    [J]. Journal of Nephrology, 2023, 36 : 829 - 839
  • [32] Induction therapy for pediatric onset class IV lupus nephritis: Mycophenolate Mofetil versus Cyclophosphamide
    Chbihi, Marwa
    Eveillard, Laurye-Anne
    Riller, Quentin
    Brousse, Romain
    Berthaud, Romain
    Quartier, Pierre
    Salomon, Remi
    Charbit, Marina
    Avramescu, Marina
    Biebuyck, Nathalie
    Dehoux, Laurene
    Garcelon, Nicolas
    Duong-Van-Huyen, Jean-Paul
    Bader-Meunier, Brigitte
    Boyer, Olivia
    [J]. JOURNAL OF NEPHROLOGY, 2023, 36 (03) : 829 - 839
  • [33] Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis
    Smith, E. M. D.
    Al-Abadi, E.
    Armon, K.
    Bailey, K.
    Ciurtin, C.
    Davidson, J.
    Gardner-Medwin, J.
    Haslam, K.
    Hawley, D.
    Leahy, A.
    Leone, V.
    McErlane, F.
    Mewar, D.
    Modgil, G.
    Moots, R.
    Pilkington, C.
    Ramanan, A.
    Rangaraj, S.
    Riley, P.
    Sridhar, A.
    Wilkinson, N.
    Beresford, M. W.
    Hedrich, C. M.
    [J]. LUPUS, 2019, 28 (05) : 613 - 620
  • [34] Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis
    Li, Xiao
    Ren, Hong
    Zhang, Qianying
    Zhang, Wen
    Wu, Xiaojing
    Xu, Yaowen
    Shen, Pingyan
    Chen, Nan
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (04) : 1467 - 1472
  • [35] Mycophenolate mofetil (MPA) versus intravenous cyclophosphamide (IVCYP) in the remission of lupus nephritis (LN)
    Goh, S. M.
    Tan, T.
    Tan, S. H.
    Liew, A.
    [J]. NEPHROLOGY, 2008, 13 : A50 - A50
  • [36] Efficacy and Adverse Events of Mycophenolate Mofetil Versus Cyclophosphamide for Induction Therapy of Lupus Nephritis Systematic Review and Meta-Analysis
    Kamanamool, Nanticha
    McEvoy, Mark
    Attia, John
    Ingsathit, Atiporn
    Ngamjanyaporn, Pintip
    Thakkinstian, Ammarin
    [J]. MEDICINE, 2010, 89 (04) : 227 - 235
  • [37] Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis
    Chan, TM
    Li, FK
    Tang, CSO
    Wong, RWS
    Fang, GX
    Ji, YL
    Lau, CS
    Wong, AKM
    Tong, MKL
    Chan, KW
    Lai, KN
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (16): : 1156 - 1162
  • [38] Cyclophosphamide versus mycophenolate mofetil for initial treatment of lupus nephritis
    Du, Xin
    Wan, Xin
    Cao, Changchun
    [J]. KIDNEY INTERNATIONAL, 2013, 83 (05) : 968 - 969
  • [39] Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis
    Isenberg, DA
    Karassa, FB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (05): : 382 - 383
  • [40] Nonrenal Disease Activity Following Mycophenolate Mofetil or Intravenous Cyclophosphamide as Induction Treatment for Lupus Nephritis
    Ginzler, Ellen M.
    Wofsy, David
    Isenberg, David
    Gordon, Caroline
    Lisk, Laura
    Dooley, Mary-Anne
    [J]. ARTHRITIS AND RHEUMATISM, 2010, 62 (01): : 211 - 221
12345